<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Medicinal Plants</title>
<title_fa>فصلنامه گياهان دارویی</title_fa>
<short_title>J. Med. Plants</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jmp.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2717-204X</journal_id_issn>
<journal_id_issn_online>2717-2058</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/jmp</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1390</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2011</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>39</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>Effect of Ethanolic Extract of &lt;i&gt;Mespilus germanica&lt;/i&gt; on Cutaneous Leishmaniasis in BALB/c Mice</title_fa>
	<title>Effect of Ethanolic Extract of &lt;i&gt;Mespilus germanica&lt;/i&gt; on Cutaneous Leishmaniasis in BALB/c Mice</title>
	<subject_fa>فارماكولوژی و سم شناسی</subject_fa>
	<subject>Pharmacology &amp; Toxicology</subject>
	<content_type_fa>پژوهشی</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Leishmaniasis is a vector-borne disease caused by flagellated protozoan parasites of the genus &lt;em&gt;Leishmania&lt;/em&gt;, which affects both humans and other mammals. Most of the available drugs against the disease are toxic and some are parasite resistance to them. &lt;strong&gt;Objective:&lt;/strong&gt; The purpose of this study was to examine the effect of &lt;em&gt;Mespilus germanica&lt;/em&gt; extract on cutaneous leishmaniasis (CL) in BALB/c Mice. &lt;strong&gt;Methods:&lt;/strong&gt; Ethanolic extract of Mespilus germanica with 40, 60 and 80% concentrations were prepared. Then, the BALB/c mice were inoculated subcutaneously by 0.1 ml liquid phase culture containing promastigotes of &lt;em&gt;Leishmania major&lt;/em&gt;. Ethanolic extract of the leaves of &lt;em&gt;Mespilus germanica&lt;/em&gt; in different concentrations, were used topically on CL lesions. &lt;strong&gt;Results:&lt;/strong&gt; The mean diameter of the lesions were decreased, and also the number of parasites in the lesions had declined with complete healing by ending the period time of treatment in 4 mice (26.7%), (p&lt; 0.05) and in 9 animals (82%), (p&lt;0.05) respectively, by using the 40% concentration of the extract. Also in a concentration of 60%, mean ulcer diameter decreased, with complete healing in 3 mice (20%), (p&lt;0.001). In this concentration, the mean number of parasites in lesions had declined (66.4%), with total elimination in 8 animals (p&lt; 0.001). &lt;strong&gt;Conclusion:&lt;/strong&gt; We showed that the extract of &lt;em&gt;Mespilus germanica&lt;/em&gt; has the highest effectiveness in concentration of 40%, causing greater reductions in both ulcer diameter and the number of parasites in the lesions compared with other prepared concentrations. Therefore, we suggest the use of 40% extract for the treatment of human cases.&lt;/div&gt;</abstract_fa>
	<abstract>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Leishmaniasis is a vector-borne disease caused by flagellated protozoan parasites of the genus &lt;em&gt;Leishmania&lt;/em&gt;, which affects both humans and other mammals. Most of the available drugs against the disease are toxic and some are parasite resistance to them. &lt;strong&gt;Objective:&lt;/strong&gt; The purpose of this study was to examine the effect of &lt;em&gt;Mespilus germanica&lt;/em&gt; extract on cutaneous leishmaniasis (CL) in BALB/c Mice. &lt;strong&gt;Methods:&lt;/strong&gt; Ethanolic extract of Mespilus germanica with 40, 60 and 80% concentrations were prepared. Then, the BALB/c mice were inoculated subcutaneously by 0.1 ml liquid phase culture containing promastigotes of &lt;em&gt;Leishmania major&lt;/em&gt;. Ethanolic extract of the leaves of &lt;em&gt;Mespilus germanica&lt;/em&gt; in different concentrations, were used topically on CL lesions. &lt;strong&gt;Results:&lt;/strong&gt; The mean diameter of the lesions were decreased, and also the number of parasites in the lesions had declined with complete healing by ending the period time of treatment in 4 mice (26.7%), (p&lt; 0.05) and in 9 animals (82%), (p&lt;0.05) respectively, by using the 40% concentration of the extract. Also in a concentration of 60%, mean ulcer diameter decreased, with complete healing in 3 mice (20%), (p&lt;0.001). In this concentration, the mean number of parasites in lesions had declined (66.4%), with total elimination in 8 animals (p&lt; 0.001). &lt;strong&gt;Conclusion:&lt;/strong&gt; We showed that the extract of &lt;em&gt;Mespilus germanica&lt;/em&gt; has the highest effectiveness in concentration of 40%, causing greater reductions in both ulcer diameter and the number of parasites in the lesions compared with other prepared concentrations. Therefore, we suggest the use of 40% extract for the treatment of human cases.&lt;/div&gt;</abstract>
	<keyword_fa>Cutaneous leishmaniasis, <i>Mespilus germanica</i>, Extract, BALB/c mice</keyword_fa>
	<keyword>Cutaneous leishmaniasis, <i>Mespilus germanica</i>, Extract, BALB/c mice</keyword>
	<start_page>76</start_page>
	<end_page>81</end_page>
	<web_url>http://jmp.ir/browse.php?a_code=A-10-147-2&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name> N</first_name>
	<middle_name></middle_name>
	<last_name>Shariatifar</last_name>
	<suffix></suffix>
	<first_name_fa>N</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Shariatifar</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>n_shariatifar@yahoo.com</email>
	<code>100319475328460037499</code>
	<orcid>100319475328460037499</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Food and Drug Deputy, Tehran University of Medical Sciences</affiliation>
	<affiliation_fa>Food and Drug Deputy, Tehran University of Medical Sciences</affiliation_fa>
	 </author>


	<author>
	<first_name> R</first_name>
	<middle_name></middle_name>
	<last_name>Rahimnia</last_name>
	<suffix></suffix>
	<first_name_fa>R</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Rahimnia</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460037500</code>
	<orcid>100319475328460037500</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Graduate, College of Medical, Tehran University of Medical Sciences</affiliation>
	<affiliation_fa>Graduate, College of Medical, Tehran University of Medical Sciences</affiliation_fa>
	 </author>


	<author>
	<first_name>AM</first_name>
	<middle_name></middle_name>
	<last_name>Jamshidi </last_name>
	<suffix></suffix>
	<first_name_fa>AM</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Jamshidi</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460037501</code>
	<orcid>100319475328460037501</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Food and Drug Deputy, Ministry of Health and Medical Education</affiliation>
	<affiliation_fa>Food and Drug Deputy, Ministry of Health and Medical Education</affiliation_fa>
	 </author>


	<author>
	<first_name> M </first_name>
	<middle_name></middle_name>
	<last_name>Pirali Hamedani</last_name>
	<suffix></suffix>
	<first_name_fa>M</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Pirali Hamedani</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460037502</code>
	<orcid>100319475328460037502</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medicinal Chemistry Department, College of Pharmacy, Tehran University of Medical Sciences</affiliation>
	<affiliation_fa>Medicinal Chemistry Department, College of Pharmacy, Tehran University of Medical Sciences</affiliation_fa>
	 </author>


	<author>
	<first_name>Sh</first_name>
	<middle_name></middle_name>
	<last_name>Shoeibi </last_name>
	<suffix></suffix>
	<first_name_fa>Sh</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Shoeibi</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460037503</code>
	<orcid>100319475328460037503</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Food and Drug Laboratory Research Center (FDLRC), Ministry of Health (MOH)</affiliation>
	<affiliation_fa>Food and Drug Laboratory Research Center (FDLRC), Ministry of Health (MOH)</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
